StockData
NovaBridge Biosciences logo

NovaBridge Biosciences (NBP) stock

NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 0/30
$0.82+0.03 (+3.89%)

Close on Nov 17, 2026Market cap $94.88MP/E –Yield –

NovaBridge Biosciences gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2021 it was 47.3%, against 100.0% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2021Dec 31, 202147.3%−52.7
FY2020Dec 31, 2020100.0%+0.0
FY2019Dec 31, 2019100.0%–

More NovaBridge Biosciences figures

See a number that looks wrong?